⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

September 16, 2024

Supplementary Figure 3 from Continuous administration of anti-VEGFA antibody upregulates PAI-1 secretion from ovarian cancer cells via miR-143-3p downregulation

Taro Yagi Kenjiro Sawada Mayuko Miyamoto Aasa Shimizu Yukako Oui Aska Toda Koji Nakamura Yasuto Kinose Michiko Kodama Kae Hashimoto Tadashi Kimura

View Full Paper

Ask AI

Bookmark

Share

Abstract

Supplementary Figure 3 shows the correlation analysis between miR-10a-5p expression and PAI-1 concentration.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Yagi et al. (2024) studied this question.

synapsesocial.com/papers/68e58589b6db6435875223db https://doi.org/10.1158/1541-7786.27035125

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Supplementary Figure 3 from Continuous administration of anti-VEGFA antibody upregulates PAI-1 secretion from ovarian cancer cells via miR-143-3p downregulation2024
2Supplementary Figure 4 from Continuous administration of anti-VEGFA antibody upregulates PAI-1 secretion from ovarian cancer cells via miR-143-3p downregulation2024
3Supplementary Figure 4 from Continuous administration of anti-VEGFA antibody upregulates PAI-1 secretion from ovarian cancer cells via miR-143-3p downregulation2024
4Supplementary Figure 7 from Continuous administration of anti-VEGFA antibody upregulates PAI-1 secretion from ovarian cancer cells via miR-143-3p downregulation2024
5Supplementary Figure 7 from Continuous administration of anti-VEGFA antibody upregulates PAI-1 secretion from ovarian cancer cells via miR-143-3p downregulation2024